Click image to view original image
Arimidex
1.other name:Anastrozole
Chemical name: α,α,α',α'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3- benzenediacetonitrile
2.Molecular formula: C17H19N5
Molecular weight: 293.37
2.Molecular formula: C17H19N5
Molecular weight: 293.37
CAS NO.: 120511-73-11
3.Quality standard:USP32
Appearance: white crystalline powder
Content: ≥ 99.5%
General introduction:Arimidex /Anastrozole is a drug used to treat breast cancer after surgery and for metastases in post-menopausal women. Anastrozole is an aromatase inhibitor, which means that it interrupts a critical step in the body's synthesis of estrogen. Some breast cancer cells require estrogen to grow, and eliminating estrogen suppresses their growth. Annual sales approx $2.2bn. The first patent expired in June 2010. Although this patent was originally set to expire in December 2009, the manufacturer was given an extension for performing much needed pediatric studies.
3.Quality standard:USP32
Appearance: white crystalline powder
Content: ≥ 99.5%
General introduction:Arimidex /Anastrozole is a drug used to treat breast cancer after surgery and for metastases in post-menopausal women. Anastrozole is an aromatase inhibitor, which means that it interrupts a critical step in the body's synthesis of estrogen. Some breast cancer cells require estrogen to grow, and eliminating estrogen suppresses their growth. Annual sales approx $2.2bn. The first patent expired in June 2010. Although this patent was originally set to expire in December 2009, the manufacturer was given an extension for performing much needed pediatric studies.
